September 30, 2025
automotive industry

WEBINAR: From Compliance to Impact and Competitive Advantage: How to Decarbonize Your Supply Chain

Share:

WEBINAR: From Compliance to Impact and Competitive Advantage: How to Decarbonize Your Supply Chain

Regulatory frameworks like the CSRD in the EU, SRS in the UK, and SB 253 & SB 261 in California are pushing sustainability to the top of the corporate agenda, but compliance is just the beginning. The real challenge and opportunity lie in taking the next step: decarbonizing the supply chain.

 

Join us for an interactive webinar where we bring together key perspectives of P3 Group, a strategic consulting partner with deep, hands-on sustainability experience in the automotive industry, and SAP, a leading enabler and technology provider supporting sustainable transformation.

 

Together, we’ll explore what it takes to move from reporting to real results. What changes are needed in your organization, your processes, and your technology stack to turn sustainability goals into measurable supply chain impact? How can decarbonization enhance your supply chain’s resilience and drive competitive advantage in international markets? Whether you’re just getting started or looking to accelerate your journey to net zero, this session will provide actionable insights you won’t want to miss.

 

Key takeaways

 

  • New regulatory frameworks are making sustainability reporting a mandatory part of corporate governance.
  • Meeting regulatory requirements is essential, but the real value lies in going beyond reporting to drive measurable decarbonization across the supply chain.
  • Organizational, process, and technology changes are necessary to shift from reporting carbon emissions to actively reducing them within your supply chain.

More Webinars

economy
play-button-webinar
webinar-person
Webinar
January 27, 2025

Breaking Through the Chaos: Supply Chain Maturity in an Age of Economic Volatility

Supply chains today are at a crossroads, grappling with unprecedented levels of complexity brought on by economic volatility, shifting geopolitical landscapes, and rapidly changing customer demands. In this Supply Chain Now webinar, hosts Scott Luton and Karin Bursa will welcome Fred Baumann, Vice President of Industry Strategy at Kinaxis, along with Ryan Goodwin, Senior Director, Advanced Supply Chain at Trinity Industries, and Lizet Tymon, VP of Supply Chain with Rehlko, for a provocative discussion exploring how organizations at different stages of supply chain maturity are responding to these challenges and preparing for the future. This session will go beyond traditional supply chain topics, diving into: The Supply Chain Maturity Curve: Insights into how organizations at varying levels of maturity—reactive, predictive, and prescriptive—are adapting their strategies to thrive in volatile conditions. Economic Resilience Through Innovation:How leading companies are leveraging cutting-edge technologies, data-driven insights, and unconventional strategies to turn uncertainty into opportunity. Shifting the Narrative: Lessons from the frontlines on breaking free from outdated paradigms to build supply chains that are not just resilient, but transformative. Whether you’re looking to reimagine your approach to supply chain maturity, navigate the pressures of economic uncertainty, or gain inspiration from unconventional success stories, this session…
Pharma
play-button-webinar
webinar-person
Webinar
April 14, 2026

Visibilidad Estratégica en Pharma: control, cumplimiento en entornos de alto riesgo

En Latinoamérica, la cadena de suministro farmacéutica no opera en condiciones ideales. Opera en entornos de variabilidad térmica extrema, infraestructura desigual, tránsitos prolongados, exposición a robo de carga y presión regulatoria constante. Y aun así, muchas organizaciones siguen tomando decisiones críticas con información tardía. Cuando una desviación se detecta al arribo, el problema ya ocurrió. Cuando un incidente de seguridad se confirma horas después, la trazabilidad ya se comprometió. Cuando la evidencia para auditoría se construye manualmente, el riesgo regulatorio ya está latente. En Pharma, la falta de visibilidad en tiempo real no es una limitación tecnológica: es una vulnerabilidad operativa.